The DOI matches its Crossref record; 47 of the 50 references it cites were found in a registry or an index.
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Open accessAbstract
The fibrillar peptide amyloid-beta (A beta) has a chief function in the pathogenesis of Alzheimer's disease. Interleukin 1 beta (IL-1 beta) is a key cytokine in the inflammatory response to A beta. Insoluble materials such as crystals activate the inflammasome formed by the cytoplasmic receptor NALP3, which results in the release of IL-1 beta. Here we identify the NALP3 inflammasome as a sensor of A beta in a process involving the phagocytosis of A beta and subsequent lysosomal damage and release of cathepsin B. Furthermore, the IL-1 beta pathway was essential for the microglial synthesis of proinflammatory and neurotoxic factors, and the inflammasome, caspase-1 and IL-1 beta were critical for the recruitment of microglia to exogenous A beta in the brain. Our findings suggest that activation of the NALP3 inflammasome is important for inflammation and tissue damage in Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Based on the previous literature42,43,46, we reasoned that cathepsin B leaking from the destabilized lysosomes may mediate the NLRP3 inflammasome activation upon SHIP1 inhibition11.”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fibrillar Aβ (fAβ), following phagocytosis by microglia, activates the NLRP3 inflammasome and leads to increases in secretion of IL-1β and IL-18.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sustained elevations of IL-1β have been postulated to play a key role in AD pathogenesis [6, 12–14].”
From 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner (2020) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Halle et al. found that fibrillar Aβ can induce the secretion of IL-1β which depends on the presence of NLRP3.352,353”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [352]
The cited source says what the claim attributes to it.
In the citing paper
“lysosomal cathepsins, such as cathepsin B, can induce NLRP3 inflammasome activation upon leaking into the cytosol following lysosomal membrane permeabilization (LMP)42,43”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [43]
The cited source says what the claim attributes to it.
In the citing paper
“fAβ phagocytosis results in lysosomal dysfunction and release of lysosomal contents into the cytoplasm, including the lysosomal protease cathepsin B, which is a mediator of inflammasome activation induced by Aβ [78].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“In line with these findings, another study showed that aggregated tau seeds activated the NLRP3 inflammasome in primary mouse microglia by inducing lysosomal destabilization and release of the lysosomal protease cathepsin B, similar to fAβ [78, 82].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“In parallel, reduction of SHIP1 activity is poised to disinhibit signaling pathways that are involved in the phagocytosis of Aβ, which is a required step for Aβ-induced activation of the NLRP3 inflammasome [78].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
In the citing paper
“Notably, Aβ also can activate NF-κB signaling and the NLRP3-ASC inflammasome [426, 427], suggesting that Aβ and tau share common mechanisms in microglia activation.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [426]
In the citing paper
“Following phagocytosis by microglia, Aβ activates the NLRP3 inflammasome leading to caspase-1 activation and IL-1β maturation and release (Halle et al., 2008).”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Halle et al., 2008
In the citing paper
“Fibrillar Aβ amyloids can induce the secretion of IL-1β from microglia, via the NLRP3 inflammasome (228, 249).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [228]
In the citing paper
“Importantly, researchers also found that ASC-, caspase-1-, IL-1 receptor-, and MyD88-deficient mice had less recruitment of microglia and mononuclear phagocytes to Aβ in the brain as compared to the wild type control after the injection of Aβ into the striatum (228).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [228]
In the citing paper
“NLRP3 has been shown to respond to sterile stimuli, including asbestos, silica, MSU and CPPD crystals55, cholesterol crystals and β-amyloid fibrils56.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“Furthermore, there is only partial inhibition of the neutrophil infiltration and IL-1β production associated with sterile inflammation in response to cholesterol crystals44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“However, cathepsin b-deficient macrophages have no impairment in IL-1β production in response to certain NLRP3 agonists, including LPS plus ATP, or MSU crystals, despite the impairment in their response to silica44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“evidence to support this are the observations that artificial lysosomal rupture alone can activate NLRP3 and that pharmacological inhibition or genetic depletion of cathepsin b results in inhibition of caspase 1 activation, although this inhibition was only partial44,56,59.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“In support of this, direct treatment of ATP on primed microglia is sufficient for maturation and release of IL-1β in vitro (Halle et al, 2008) and does so via the P2X 7 receptor (Colomar et al, 2003) expressed on microglia (Monif et al, 2009).”
From Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal (2017) · cites this paper as Halle et al, 2008
In the citing paper
“In particular, microglial NLRP3 has been shown to be a major driver of amyloid beta and tau toxicity in AD, suggesting its activation has important implications for disease progression (Halle et al, 2008; Venegas et al, 2017; Ising et al, 2019).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Halle et al, 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
Lois, C., Hong, E. J., Pease, S., Brown, E. J., & Baltimore, D. (2002) · Science · doi:10.1126/science.1067081 · Cited by 1,992
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme
Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S. S., & Flavell, R. A. (1995) · Science · doi:10.1126/science.7535475 · Cited by 1,631
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Flagged first, then by citations
3 of the 50 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 701–800 of 1,015
The inflammasome: in memory of Dr. Jurg Tschopp
Dagenais, M., Skeldon, A. M., & Saleh, M. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.159 · Cited by 92
Genipin inhibits NLRP3 and NLRC4 inflammasome activation via autophagy suppression
Yu, S.-X., Du, C., Chen, W., Lei, Q.-Q., Li, N., Qi, S., Zhang, X.-J., Hu, G., Deng, X., Han, W., et al. (2015) · Scientific Reports · doi:10.1038/srep17935 · Cited by 86
Mohamed, I., Ishrat, T., Fagan, S. C., & El‐Remessy, A. B. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6126 · Cited by 88
Chen, T.-T., Lan, T., & Yang, F. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy039 · Cited by 88
Friend, Foe or Both? Immune Activity in Alzheimer’s Disease
Frost, G. R., Jonas, L. A., & Li, Y. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00337 · Cited by 88
Natural compounds flavonoids as modulators of inflammasomes in chronic diseases
Owona, B. A., Abia, W. A., & Moundipa, P. F. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106498 · Cited by 88
Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
Guan, Y., & Han, F. (2020) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2020.00037 · Cited by 90
Role of NLRP3 Inflammasome in Parkinson’s Disease and Therapeutic Considerations
Nguyen, L. T. N., Nguyễn, H. Đ., Kim, Y. J., Nguyen, T. T., Lai, T. T., Lee, Y. K., Ma, H., & Kim, Y. E. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223290 · Cited by 90
Innate immune sensing of cell death in disease and therapeutics
Man, S. M., & Kanneganti, T. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01491-y · Cited by 94
Inflammation-induced DNA damage and damage-induced inflammation: a vicious cycle
Palmai‐Pallag, T., & Bachrati, C. Z. (2014) · Microbes and Infection · doi:10.1016/j.micinf.2014.10.001 · Cited by 88
Zhang, A., Wang, P., Ma, X., Yin, X., Li, J., Wang, H., Jiang, W., Jia, Q., & Ni, L. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.03.009 · Cited by 87
Vaine, C. A., Patel, M. K., Zhu, J., Lee, E. J., Finberg, R. W., Hayward, R. C., & Kurt‐Jones, E. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200492 · Cited by 87
Jha, S., & Ting, J. P. ‐. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902425 · Cited by 88
Electrophilic Warhead-Based Design of Compounds Preventing NLRP3 Inflammasome-Dependent Pyroptosis
Cocco, M., Garella, D., Stilo, A. D., Borretto, E., Stevanato, L., Giorgis, M., Marini, E., Fantozzi, R., Miglio, G., & Bertinaria, M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501072b · Cited by 87
Sevenich, L., Werner, F., Gajda, M., Schurigt, U., Sieber, C., Müller, S., Follo, M., Peters, C., & Reinheckel, T. (2011) · Oncogene · doi:10.1038/onc.2010.387 · Cited by 85
Self-citationZhuang, Y., Ding, G., Zhao, M., Bai, M., Yang, L., Ni, J., Wang, R., Jia, Z., Huang, S., & Zhang, A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.578260 · Cited by 86
NLRP3 polymorphisms are associated with late-onset Alzheimer's disease in Han Chinese
Tan, M., Yu, J., Jiang, T., Zhu, X., Wang, H.-F., Zhang, W., Wang, Y., Jiang, W., & Tan, L. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.10.002 · Cited by 89
Wu, L., Wu, S.-G., Chen, F., Wu, Q., Wu, C.-M., Kang, C., He, X., Zhang, R., Lu, Z.-F., Li, X.-H., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.11.033 · Cited by 86
Wu, Y., Gong, Y., Luan, Y., Li, Y., Liu, J., Yue, Z., Yuan, B., Sun, J., Xie, C., Li, L., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901984r · Cited by 85
Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer’s Disease
Wu, L., Xian, X., Xu, G., Tan, Z., Dong, F., Zhang, M., & Zhang, F. (2022) · Mediators of Inflammation · doi:10.1155/2022/7924199 · Cited by 93
Xuan, A., Xue-bing, P., Wei, P., Ji, W., Zhang, W.-J., Liu, J., Hong, L.-P., Chen, W., & Long, D. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8751-4 · Cited by 91
He, J., Zhao, X., Xu, L., & Mao, C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190764 · Cited by 88
de Dios, C., Abadin, X., Roca-Agujetas, V., Jimenez-Martinez, M., Morales, A., Trullas, R., Mari, M., & Colell, A. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00343-3 · Cited by 85
Wu, P.-J., Hung, Y.-F., Liu, H., & Hsueh, Y. (2017) · NeuroImmunoModulation · doi:10.1159/000477092 · Cited by 85
Pirzada, R. H., Javaid, N., & Choi, S. (2020) · Genes · doi:10.3390/genes11020131 · Cited by 84
Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
Anderson, F. L., von Herrmann, K. M., Andrew, A. S., Kuras, Y. I., Young, A. L., Scherzer, C. R., Hickey, W. F., Lee, S., & Havrda, M. C. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-020-00147-6 · Cited by 89
Decoding Mast Cell-Microglia Communication in Neurodegenerative Diseases
Sandhu, J. K., & Kulka, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031093 · Cited by 90
Inflammasome assembly in neurodegenerative diseases
Singh, J., Habean, M. L., & Panicker, N. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.07.009 · Cited by 83
Liu, R. T., Wang, A., To, E. C., Gao, J., Cao, S., Cui, J. Z., & Matsubara, J. A. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.07.003 · Cited by 84
Network-wide dysregulation of calcium homeostasis in Alzheimer’s disease
Brawek, B., & Garaschuk, O. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1798-8 · Cited by 83
Regulation of NOD‐like receptors and inflammasome activation in cerebral endothelial cells
Nagyőszi, P., Nyúl‐Tóth, Á., Fazakas, C., Wilhelm, I., Kozma, M., Molnár, J., Haskó, J., & Krizbai, I. A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13197 · Cited by 82
Burm, S. M., Zuiderwijk-Sick, E. A., ‘t Jong, A. E. J., van der Putten, C., Veth, J., Kondova, I., & Bajramovic, J. J. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2510-14.2015 · Cited by 82
Gao, J., Cui, J. Z., To, E., Cao, S., & Matsubara, J. A. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1062-3 · Cited by 83
Propofol Inhibits NLRP3 Inflammasome and Attenuates Blast-Induced Traumatic Brain Injury in Rats
Ma, J., Xiao, W., Wang, J., Wu, J., Ren, J., Hou, J., Gu, J., Fan, K., & Yu, B. (2016) · Inflammation · doi:10.1007/s10753-016-0446-8 · Cited by 84
Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases
Sonninen, T.-M., Goldsteins, G., Laham-Karam, N., Koıstınaho, J., & Lehtonen, Š. (2020) · Cells · doi:10.3390/cells9102183 · Cited by 89
Kuwar, R., Rolfe, A., Di, L., Blevins, H., Xu, Y., Sun, X., Bloom, G. S., Zhang, S., & Sun, D. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210400 · Cited by 82
Hook, G., Yu, J., Toneff, T., Kindy, M. S., & HOOK, V. Y. H. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131370 · Cited by 87
Negative regulation of NLRP3 inflammasome signaling
Chen, S., & Sun, B. (2013) · Protein & Cell · doi:10.1007/s13238-013-2128-8 · Cited by 84
Kato, J., & Svensson, C. I. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.11.014 · Cited by 85
Shridas, P., de Beer, M. C., & Webb, N. R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002428 · Cited by 84
Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules
Seok, J. K., Kang, H. C., Cho, Y., Lee, H. S., & Lee, J. Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.618231 · Cited by 88
Ratan, Y., Rajput, A., Maleysm, S., Pareek, A., Jain, V. K., Pareek, A., Kaur, R., & Singh, G. (2023) · Biomedicines · doi:10.3390/biomedicines11051398 · Cited by 89
The Evolving Biology of Microglia in Alzheimer's Disease
Malm, T. M., Jay, T. R., & Landreth, G. E. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0316-8 · Cited by 85
Thundyil, J., & Lim, K. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.11.003 · Cited by 85
Denver, P., & McClean, P. L. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.238608 · Cited by 89
Crosstalk between Autophagy and Inflammasomes
Yuk, J., & Jo, E. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0298-0 · Cited by 82
Inflammasome and cytokine blocking strategies in autoinflammatory disorders
Moll, M., & Kuemmerle-Deschner, J. B. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.04.008 · Cited by 85
Ten Challenges of the Amyloid Hypothesis of Alzheimer’s Disease
Kepp, K. P. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160550 · Cited by 83
Neurodegeneration and NLRP3 inflammasome expression in the anterior thalamus of SOD1(G93A) ALS mice
Debye, B., Schmülling, L., Zhou, L., Rune, G., Beyer, C., & Johann, S. (2018) · Brain Pathology · doi:10.1111/bpa.12467 · Cited by 81
Ginsenoside Rg3 suppresses the NLRP3 inflammasome activation through inhibition of its assembly
Shi, Y., Wang, H., Zheng, M., Xu, W., Yang, Y., & Shi, F. (2019) · The FASEB Journal · doi:10.1096/fj.201901537r · Cited by 85
Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective
Suryavanshi, S. V., Kovalchuk, I., & Kovalchuk, O. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613613 · Cited by 87
Lu, R. O., Pan, H., & Shively, J. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002597 · Cited by 79
HIV-1 Induces the First Signal to Activate the NLRP3 Inflammasome in Monocyte-Derived Macrophages
Hernández, J. C., Latz, E., & Inchima, S. U. (2013) · Intervirology · doi:10.1159/000353902 · Cited by 79
Self-citationA rat model of ataxia-telangiectasia: evidence for a neurodegenerative phenotype
Quek, H., Luff, J., Cheung, K., Kozlov, S., Gatei, M. H., Lee, C. S., Bellingham, M. C., Noakes, P. G., Lim, Y. C., Barnett, N. L., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw371 · Cited by 80
The Inhibition of Inflammasome by Brazilian Propolis (EPP-AF)
Hori, J. I., Zamboni, D. S., Carrão, D. B., Goldman, G. H., & Berretta, A. A. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/418508 · Cited by 82
Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome
Shim, D.-W., & Lee, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01054 · Cited by 80
Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases
Guo, D., Liu, Z., Zhou, J., Ke, C., & Li, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189947 · Cited by 83
Klettner, A., Kauppinen, A., Błasiak, J., Roider, J., Salminen, A., & Kaarniranta, K. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.04.013 · Cited by 83
Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors
Cocco, M., Miglio, G., Giorgis, M., Garella, D., Marini, E., Costale, A., Regazzoni, L., Vistoli, G., Orioli, M., Massulaha‐Ahmed, R., et al. (2016) · ChemMedChem · doi:10.1002/cmdc.201600055 · Cited by 80
The role of the inflammasome in patients with autoinflammatory diseases
Hoffman, H. M., & Broderick, L. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.05.001 · Cited by 80
NLRP3-dependent synaptic plasticity deficit in an Alzheimer's disease amyloidosis model in vivo
Qi, Y., Klyubin, I. V., Cuello, A. C., & Rowan, M. J. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.02.016 · Cited by 80
MicroRNAs as important regulators of the NLRP3 inflammasome
Zamani, P., Oskuee, R. K., Atkin, S. L., Navashenaq, J. G., & Sahebkar, A. (2019) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2019.05.004 · Cited by 80
The role of NLRP3 inflammasome activation in radiation damage
Wei, J., Wang, H., Wang, H., Wang, B., Meng, L., Xin, Y., & Jiang, X. M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109217 · Cited by 80
INPP5D regulates inflammasome activation in human microglia
Chou, V., Pearse, R. V., Aylward, A. J., Ashour, N., Taga, M., Terzioglu, G., Fujita, M., Fancher, S. B., Sigalov, A., Benoit, C. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42819-w · Cited by 79
Mortimer, L. M., Moreau, F., Cornick, S., & Chadee, K. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004887 · Cited by 79
Lysosomal membrane homeostasis and its importance in physiology and disease
Radulovic, M., Yang, C., & Stenmark, H. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00873-w · Cited by 89
Migration of blood cells to β-amyloid plaques in Alzheimer's disease
Hohsfield, L. A., & Humpel, C. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.03.002 · Cited by 79
Microglia as a critical player in both developmental and late-life CNS pathologies
Derecki, N. C., Katzmarski, N., Kipnis, J., & Meyer-Luehmann, M. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1321-z · Cited by 78
The NLRP 3 inflammasome: role in airway inflammation
Im, H., & Ammit, A. J. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12206 · Cited by 80
Nickel Induces Interleukin-1β Secretion via the NLRP3–ASC–Caspase-1 Pathway
Li, X., & Zhong, F. (2013) · Inflammation · doi:10.1007/s10753-013-9759-z · Cited by 78
Activating immunity: lessons from the TLRs and NLRs
Monie, T. P., Bryant, C. E., & Gay, N. J. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.06.011 · Cited by 80
Exploring the role of microglia in cortical spreading depression in neurological disease
Shibata, M., & Suzuki, N. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17690537 · Cited by 81
Immortalization of Murine Bone Marrow-Derived Macrophages
Nardo, D. D., Kalvakolanu, D. V., & Latz, E. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7837-3_4 · Cited by 76
Self-citationMechanisms of action of amyloid-beta and its precursor protein in neuronal cell death
Leong, Y. Q., Ng, K. Y., Chye, S. M., Ling, A. P. K., & Koh, R. Y. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00516-y · Cited by 80
Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer’s Disease
Yang, Y., & Zhang, Z. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00110 · Cited by 76
The roles of microglia and astrocytes in neuroinflammation of Alzheimer’s disease
Han, J., Zhang, Z., Zhang, P., Yu, Q., Cheng, Q., Lu, Z., & Zong, S. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1575453 · Cited by 97
Genetic and Molecular Basis of Inflammasome-mediated Disease
Hoffman, H. M., & Brydges, S. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.135491 · Cited by 79
The Role of NLR-related Protein 3 Inflammasome in Host Defense and Inflammatory Diseases
Yang, C., Shin, D., & Jo, E. (2012) · International Neurourology Journal · doi:10.5213/inj.2012.16.1.2 · Cited by 81
Xue, Y., Du, ., & Zhu, M. J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.05.003 · Cited by 79
Santos, D. F., Campos, T. M., Saldanha, M. G., Oliveira, S. C., Nascimento, M. T., Zamboni, D. S., Machado, P. R. L., Arruda, S. M., Scott, P., Carvalho, E. M., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.11.029 · Cited by 77
Ma, L., Yang, C., Zhang, X., Li, Y., Wang, S. L., Zheng, L., & Huang, K. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.003 · Cited by 78
Rodríguez-Alcázar, J. F., Ataide, M. A., Engels, G., Schmitt-Mabmunyo, C., Garbi, N., Kastenmüller, W., Latz, E., & Franklin, B. S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800107 · Cited by 77
Self-citationThe NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation
Huppertz, C., Jäger, B., Wieczorek, G., Engelhard, P., Oliver, S. J., Bauernfeind, F., Littlewood-Evans, A. J., Welte, T., Hornung, V., & Prasse, A. (2020) · European Respiratory Journal · doi:10.1183/13993003.00119-2019 · Cited by 85
Self-citationEmerging roles of microglial cathepsins in neurodegenerative disease
Lowry, J. R., & Klegeris, A. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.02.014 · Cited by 77
The role of microglia mediated pyroptosis in neonatal hypoxic-ischemic brain damage
Lv, Y., Sun, B., Lu, X.-X., Liu, Y., Li, M., Xu, L., Feng, C., Ding, X., & Feng, X. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.003 · Cited by 77
Neurovascular Inflammaging in Health and Disease
Mészáros, Á., Molnár, K., Nógrádi, B., Hernádi, Z., Nyúl‐Tóth, Á., Wilhelm, I., & Krizbai, I. A. (2020) · Cells · doi:10.3390/cells9071614 · Cited by 86
Kim, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062929 · Cited by 77
Cui, Y., Yu, H., Bu, Z., Wen, L., Yan, L.-L., & Feng, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.894298 · Cited by 80
Inflammasome: structure, biological functions, and therapeutic targets
Dai, Y., Zhou, J., & Shi, C. (2023) · MedComm · doi:10.1002/mco2.391 · Cited by 89
Fruhwürth, S., Zetterberg, H., & Paludan, S. R. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578342 · Cited by 77
Dissemination of Orientia tsutsugamushi and Inflammatory Responses in a Murine Model of Scrub Typhus
Keller, C. A., Hauptmann, M., Kolbaum, J., Gharaibeh, M. H., Neumann, M., Glatzel, M., & Fleischer, B. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003064 · Cited by 77
Inflammasomes and Their Activation
Khare, S., Luc, N., Dorfleutner, A., & Stehlik, C. (2010) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v30.i5.50 · Cited by 77
Kinoshita, T., Imamura, R., Kushiyama, H., & Suda, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119179 · Cited by 80
Bitto, N. J., Baker, P. J., Dowling, J. K., Wray‐McCann, G., Paoli, A. D., Tran, L. S., Leung, P. L., Stacey, K. J., Mansell, A. S., Masters, S. L., et al. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12190 · Cited by 80
Complementing the inflammasome
Triantafilou, M., Hughes, T. R., Morgan, B. P., & Triantafilou, K. (2016) · Immunology · doi:10.1111/imm.12556 · Cited by 76
The role of the inflammasome in nonmyeloid cells
Yazdi, A. S., Drexler, S. K., & Tschopp, J. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9437-y · Cited by 76
Programmed Death of Microglia in Alzheimer's Disease: Autophagy, Ferroptosis, and Pyroptosis
Qiu, Z., Zhang, H., Xia, M., Gu, J., Guo, K., Wang, H., & Miao, C. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.3 · Cited by 77
NLRP3 inflammasome as a sensor of micro- and nanoplastics immunotoxicity
Alijagić, A., Hedbrant, A., Persson, A., Larsson, M., Engwall, M., & Särndahl, E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1178434 · Cited by 78
Tetrahydroxy stilbene glycoside ameliorates neuroinflammation for Alzheimer's disease via cGAS-STING
Gao, D., Hao, J.-P., Li, B., Zheng, C.-C., Miao, B.-B., Zhang, L., Li, Y., Li, L., Li, X., & Zhang, L. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175809 · Cited by 82
Inflammasomes: Mechanisms of Action and Involvement in Human Diseases
Bulté, D., Rigamonti, C., Romano, A., & Mortellaro, A. (2023) · Cells · doi:10.3390/cells12131766 · Cited by 83
Metadata
- Authors
- Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Harvard University (US)
- University of Freiburg (DE)
- Corresponding author
- Golenbock, Douglas T
- ORCID
- Venue
- Nature Immunology
- Published
- 2008-07-11
- Volume
- 9
- Issue
- 8
- Pages
- 857-865
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC3101478
- OpenAlex
- W2119098586
- Cited by
- 2,441
- References
- 50
- Citations by year
- 2026: 92 · 2025: 124 · 2024: 143 · 2023: 165 · 2022: 191 · 2021: 188 · 2020: 169 · 2019: 151 · 2018: 136 · 2017: 139 · 2016: 138 · 2015: 146 · 2014: 149 · 2013: 153 · 2012: 98
- FWCI
- 35.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship@UMassChan (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- National Institute on Aging (R01AG020255, AG20255)
- National Institute of General Medical Sciences (R37GM054060, R01GM054060, GM 54060)
- National Institute of Allergy and Infectious Diseases (AI065483, R01AI065483)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- NLRP3 inflammasome, amyloid-beta, Alzheimer's disease, innate immunity, IL-1β, caspase-1, microglia, phagocytosis, lysosomal damage, cathepsin B, neuroinflammation, neurotoxicity
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Alzheimer Disease, Carrier Proteins, Immunity, Innate, Inflammation, Amyloid beta-Peptides, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
